Option chain shows key data for Beiersdorf's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Beiersdorf.

Beiersdorf (OTC:BDRFY) Stock, Option Chain

Beiersdorf

BEIERSDORF A G

Beiersdorf is a Germany-based company that produces personal care products, with a focus on manufacturing cosmetic products. The company operates through two business segments. Consumer provides skincare and beauty care products and operates portfolio brands such as Nivea, Eucerin, La Prairie, Labello, Hansaplast, Elastoplast, and Florena. The other business segment markets self-adhesive system and product solutions, primarily for industrial customers, under the Tesa brand. Beiersdorf is majority-owned by Maxingvest.

News

Intraday Update

Markets

Movers

Trading Ideas

ACGL

ACKRF

ADPT

AFTPF

ASMIY

AUTLF

BCEKF

BDRFY

BF-A

BF-B

BSDGF

CABO

CHOLF

CHTR

CLHI

CLHRF

COUP

DBOEY

DCGD

ELRFF

EPGG

EPRT

ESGRP

EVRG

GATGF

GNMLF

GPTX

GTBDF

HCHDF

HCHMY

HEBT

HELE

HLTEF

HMLA

IBDRY

IMKTA

IMOS

INFO

INVH

JBSS

KLAC

KNSL

LAHO

LOOP

MDLZ

MLYCF

MSMGF

NMGNF

NSRGF

Nestle Sponsored representing Registered Shares Series B

NSRGY

NTDOY

Nuveen Insured Dividend Advantage Municipal Fund

NXRT

NXTC

Stocks That Hit 52-Week Highs On Wednesday

ACLLF

ALIAF

ANPDY

ATUS

AUCOY

AVACF

CASH

CBLK

CDLX

CELTF

CGXEF

CMXC

COST

CRGE

CVNA

DRRX

DXCM

ENPH

FBPRN

FRHC

GRWG

HEI-A

HUBS

LPSN

MDCO

MGPRF

MKTX

Nuveen Dividend Advantage Municipal Fund 3

ORZCF

PAAS

PCTY

PEGI

PFSI

RGLD

RSLBF

SBAC

SHOS

SPNS

SSPXF

STOK

TERP

TLRA

USFD

FLMZF

PAHGF

DREUF

DRDGF

GLGDF

KOOYF

CMLGF

Stocks That Hit 52-Week Highs On Tuesday

ANIK

ATAX

ATLC

CCRN

CDPYF

CEVA

CHNG

CNMD

CPRX

CSII

CTAS

CUBE

EVER

FORTY

IDNG

IRET

JJSF

KRUS

NRILY

PCTI

PERI

PFMS

RADA

RUBI

SIGI

SWCH

TACYY

TNAV

TPVG

TSGZF

UEHPY

VCISF

WELL

AGGFF

HRNNF

INGIF

IWGFF

IBIO

Beiersdorf AG

<h2>Upgrades</h2>
For Bouygues (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BOUYF#OTC">BOUYF</a>), Jefferies upgraded the previous rating of Hold to Buy. At the moment, the stock has a 52-week-high of $43.06 and a 52-week-low of $33.96. Bouygues closed at $42.20 at the end of the last trading period. 
Berenberg upgraded the previous rating for SES SA (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SGBAF#OTC">SGBAF</a>) from Hold to Buy. The stock has a 52-week-high of $10.31 and a 52-week-low of $6.64. At the end of the last trading period, SES closed at $8.56. 
According to Citigroup, the prior rating for The Western Union Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WU#NYSE">WU</a>) was changed from Neutral to Buy. The Western Union earned $0.48 in the second quarter, compared to $0.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $26.61 and a 52-week-low of $19.07. The Western Union closed at $20.66 at the end of the last trading period. 
For Aurora Cannabis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>), MKM Partners upgraded the previous rating of Sell to Neutral. In the fourth quarter, Aurora Cannabis showed an EPS of $0.55, compared to $13.34 from the year-ago quarter. The current stock performance of Aurora Cannabis shows a 52-week-high of $18.98 and a 52-week-low of $3.71. Moreover, at the end of the last trading period, the closing price was at $6.38. 
According to Wolfe Research, the prior rating for Chewy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) was changed from Peer Perform to Outperform. Chewy earned $0.04 in the second quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $120.00 and a 52-week-low of $54.55. Chewy closed at $70.50 at the end of the last trading period. 
Morgan Stanley upgraded the previous rating for Okta Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) from Equal-Weight to Overweight. In the second quarter, Okta showed an EPS of $0.11, compared to $0.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $294.00 and a 52-week-low of $199.08. Okta closed at $241.46 at the end of the last trading period. 
According to JMP Securities, the prior rating for AG Mortgage Investment Trust Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITT#NYSE">MITT</a>) was changed from Market Perform to Market Outperform. AG Mortgage Investment earned $0.00 in the second quarter, compared to $0.09 in the year-ago quarter. The current stock performance of AG Mortgage Investment shows a 52-week-high of $11.48 and a 52-week-low of $2.51. Moreover, at the end of the last trading period, the closing price was at $11.26. 
Barclays upgraded the previous rating for Sirius XM Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>) from Underweight to Equal-Weight. Sirius XM Holdings earned $0.07 in the second quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $8.14 and a 52-week-low of $5.01. At the end of the last trading period, Sirius XM Holdings closed at $6.11. 
For Harpoon Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HARP#NASDAQ">HARP</a>), Citigroup upgraded the previous rating of Neutral to Buy. For the second quarter, Harpoon Therapeutics had an EPS of $0.52, compared to year-ago quarter EPS of $0.51. At the moment, the stock has a 52-week-high of $25.23 and a 52-week-low of $7.92. Harpoon Therapeutics closed at $8.01 at the end of the last trading period. 
Citigroup upgraded the previous rating for Puma Biotechnology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBYI#NASDAQ">PBYI</a>) from Neutral to Buy. In the second quarter, Puma Biotechnology showed an EPS of $0.13, compared to $0.35 from the year-ago quarter. The current stock performance of Puma Biotechnology shows a 52-week-high of $14.14 and a 52-week-low of $6.48. Moreover, at the end of the last trading period, the closing price was at $7.12. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
<h2>Downgrades</h2>
According to Bernstein, the prior rating for Beiersdorf AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BDRFY#OTC">BDRFY</a>) was changed from Market Perform to Underperform. At the moment, the stock has a 52-week-high of $25.36 and a 52-week-low of $20.77. Beiersdorf closed at $23.15 at the end of the last trading period. 
Craig-Hallum downgraded the previous rating for Purple Innovation Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPL#NASDAQ">PRPL</a>) from Buy to Hold. Purple Innovation earned $0.05 in the second quarter, compared to $0.11 in the year-ago quarter. The stock has a 52-week-high of $41.08 and a 52-week-low of $21.69. At the end of the last trading period, Purple Innovation closed at $23.01. 
Berenberg downgraded the previous rating for Eutelsat Communications (OTC:<a class="ticker" href="https://www.benzinga.com/stock/EUTLF#OTC">EUTLF</a>) from Buy to Hold. At the moment, the stock has a 52-week-high of $12.75 and a 52-week-low of $9.55. Eutelsat Comms closed at $11.95 at the end of the last trading period. 
For Surgalign Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRGA#NASDAQ">SRGA</a>), Craig-Hallum downgraded the previous rating of Buy to Hold. For the second quarter, Surgalign Holdings had an EPS of $0.09, compared to year-ago quarter EPS of $0.32. The stock has a 52-week-high of $3.27 and a 52-week-low of $0.88. At the end of the last trading period, Surgalign Holdings closed at $1.23. 
According to Loop Capital, the prior rating for Kraton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRA#NYSE">KRA</a>) was changed from Buy to Hold. Kraton earned $0.32 in the second quarter, compared to $0.30 in the year-ago quarter. At the moment, the stock has a 52-week-high of $45.88 and a 52-week-low of $15.87. Kraton closed at $45.41 at the end of the last trading period. 
According to New Street Research, the prior rating for ASML Holding NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) was changed from Buy to Neutral. ASML Holding earned $3.04 in the second quarter, compared to $1.97 in the year-ago quarter. The current stock performance of ASML Holding shows a 52-week-high of $895.93 and a 52-week-low of $351.09. Moreover, at the end of the last trading period, the closing price was at $835.31. 
For Wells Fargo &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. In the second quarter, Wells Fargo showed an EPS of $1.38, compared to $0.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $51.41 and a 52-week-low of $20.76. Wells Fargo closed at $47.56 at the end of the last trading period. 
Berenberg downgraded the previous rating for Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) from Buy to Hold. For the second quarter, Morgan Stanley had an EPS of $1.89, compared to year-ago quarter EPS of $1.96. At the moment, the stock has a 52-week-high of $105.81 and a 52-week-low of $45.91. Morgan Stanley closed at $105.10 at the end of the last trading period. 
According to New Street Research, the prior rating for Applied Materials Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) was changed from Buy to Neutral. In the third quarter, Applied Materials showed an EPS of $1.90, compared to $1.06 from the year-ago quarter. The stock has a 52-week-high of $146.00 and a 52-week-low of $56.65. At the end of the last trading period, Applied Materials closed at $142.74. 
Jefferies downgraded the previous rating for Travel+Leisure Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNL#NYSE">TNL</a>) from Buy to Hold. In the second quarter, Travel+Leisure showed an EPS of $0.88, compared to $1.11 from the year-ago quarter. The stock has a 52-week-high of $68.26 and a 52-week-low of $48.01. At the end of the last trading period, Travel+Leisure closed at $59.54. 
Citigroup downgraded the previous rating for Hess Midstream LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HESM#NYSE">HESM</a>) from Buy to Neutral. For the second quarter, Hess Midstream had an EPS of $0.44, compared to year-ago quarter EPS of $0.29. The current stock performance of Hess Midstream shows a 52-week-high of $30.34 and a 52-week-low of $14.56. Moreover, at the end of the last trading period, the closing price was at $29.04. 
For Logitech International SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>), Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. For the first quarter, Logitech International had an EPS of $1.22, compared to year-ago quarter EPS of $0.64. The current stock performance of Logitech International shows a 52-week-high of $140.17 and a 52-week-low of $71.72. Moreover, at the end of the last trading period, the closing price was at $96.78. 
According to Keybanc, the prior rating for MGM Growth Properties LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGP#NYSE">MGP</a>) was changed from Overweight to Sector Weight. MGM Growth Properties earned $0.65 in the second quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $43.19 and a 52-week-low of $25.84. MGM Growth Properties closed at $40.16 at the end of the last trading period. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
<h2>Initiations</h2>
Jefferies initiated coverage on Redwire Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) with a Buy rating. The price target for Redwire is set to $15.00. The current stock performance of Redwire shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $9.99. 
With an Outperform rating, Evercore ISI Group initiated coverage on United Parcel Service Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>). The price target seems to have been set at $225.00 for United Parcel Service. In the second quarter, United Parcel Service showed an EPS of $3.06, compared to $2.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $219.59 and a 52-week-low of $154.76. United Parcel Service closed at $186.84 at the end of the last trading period. 
With a Neutral rating, B of A Securities initiated coverage on LiveVox Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVOX#NASDAQ">LVOX</a>). The price target seems to have been set at $8.00 for LiveVox Hldgs. In the second quarter, LiveVox Hldgs earned $1.08. At the moment, the stock has a 52-week-high of $9.45 and a 52-week-low of $5.79. LiveVox Hldgs closed at $6.73 at the end of the last trading period. 
JMP Securities initiated coverage on Coinbase Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) with a Market Outperform rating. The price target for Coinbase Global is set to $300.00. Coinbase Global earned $6.42 in the second quarter. At the moment, the stock has a 52-week-high of $429.54 and a 52-week-low of $208.00. Coinbase Global closed at $232.24 at the end of the last trading period. 
Berenberg initiated coverage on ThredUp Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDUP#NASDAQ">TDUP</a>) with a Hold rating. The price target for ThredUp is set to $21.00. ThredUp earned $0.15 in the second quarter. The stock has a 52-week-high of $31.86 and a 52-week-low of $14.23. At the end of the last trading period, ThredUp closed at $21.03. 
Berenberg initiated coverage on Poshmark Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POSH#NASDAQ">POSH</a>) with a Buy rating. The price target for Poshmark is set to $42.00. In the second quarter, Poshmark earned $0.04. The current stock performance of Poshmark shows a 52-week-high of $104.98 and a 52-week-low of $23.27. Moreover, at the end of the last trading period, the closing price was at $24.01. 
With a Buy rating, Jefferies initiated coverage on Airspan Networks Holdings Inc (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MIMO#AMEX">MIMO</a>). The price target seems to have been set at $11.00 for Airspan Networks Hldgs. Interestingly, in the second quarter, Airspan Networks Hldgs's EPS was $18.68. At the moment, the stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Airspan Networks Hldgs closed at $7.09 at the end of the last trading period. 
With a Buy rating, Needham initiated coverage on Otonomo Technologies Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTMO#NASDAQ">OTMO</a>). The price target seems to have been set at $10.00 for Otonomo Technologies. The current stock performance of Otonomo Technologies shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $4.78. 
HC Wainwright &amp; Co. initiated coverage on Kintara Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) with a Buy rating. The price target for Kintara Therapeutics is set to $6.00. In the third quarter, Kintara Therapeutics showed an EPS of $0.23, compared to $0.17 from the year-ago quarter. The current stock performance of Kintara Therapeutics shows a 52-week-high of $3.35 and a 52-week-low of $0.88. Moreover, at the end of the last trading period, the closing price was at $0.88. 
With a Buy rating, UBS initiated coverage on Howmet Aerospace Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>). The price target seems to have been set at $40.00 for Howmet Aerospace. Howmet Aerospace earned $0.22 in the second quarter, compared to $0.12 in the year-ago quarter. The stock has a 52-week-high of $36.03 and a 52-week-low of $16.26. At the end of the last trading period, Howmet Aerospace closed at $33.00. 
Oppenheimer initiated coverage on Blade Air Mobility Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>) with an Outperform rating. The price target for Blade Air Mobility is set to $14.00. In the third quarter, Blade Air Mobility earned $0.15. The current stock performance of Blade Air Mobility shows a 52-week-high of $11.99 and a 52-week-low of $6.41. Moreover, at the end of the last trading period, the closing price was at $11.27. 
With an Outperform rating, Oppenheimer initiated coverage on Lilium NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILM#NASDAQ">LILM</a>). The price target seems to have been set at $24.00 for Lilium. The current stock performance of Lilium shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $10.61. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Initiation

Analyst Ratings

AMAT

ASML

BLDE

BOUYF

CHWY

COIN

EUTLF

HARP

HESM

Kintara Therapeutics, Inc. - Common Stock

KTRA

LILM

LOGI

LVOX

Airspan Networks Holdings Inc. Common Stock

MIMO

MITT

OKTA

OTMO

PBYI

POSH

PRPL

SGBAF

SIRI

SRGA

TDUP

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2021

Bernstein analyst Bruno Monteyne downgrades Beiersdorf (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BDRFY#OTC">BDRFY</a>) from Market Perform to Underperform.

Bernstein Downgrades Beiersdorf to Underperform

&nbsp;
<h2>Upgrades</h2>
<ul>
<li>According to Benchmark, the prior rating for TopBuild Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLD#NYSE">BLD</a>) was changed from Hold to Buy. In the second quarter, TopBuild showed an EPS of $2.76, compared to $1.68 from the year-ago quarter. At the moment, the stock has a 52-week-high of $235.50 and a 52-week-low of $144.58. TopBuild closed at $219.98 at the end of the last trading period.</li>
<li>For Belden Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDC#NYSE">BDC</a>), Canaccord Genuity upgraded the previous rating of Hold to Buy. For the second quarter, Belden had an EPS of $1.21, compared to year-ago quarter EPS of $0.46. At the moment, the stock has a 52-week-high of $58.54 and a 52-week-low of $28.55. Belden closed at $56.96 at the end of the last trading period.</li>
<li>For NeoPhotonics Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPTN#NYSE">NPTN</a>), Raymond James upgraded the previous rating of Underperform to Market Perform. For the second quarter, NeoPhotonics had an EPS of $0.22, compared to year-ago quarter EPS of $0.16. At the moment, the stock has a 52-week-high of $14.14 and a 52-week-low of $5.75. NeoPhotonics closed at $9.39 at the end of the last trading period.</li>
<li>SVB Leerink upgraded the previous rating for HealthEquity Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) from Market Perform to Outperform. HealthEquity earned $0.40 in the second quarter, compared to $0.42 in the year-ago quarter. The stock has a 52-week-high of $93.32 and a 52-week-low of $45.82. At the end of the last trading period, HealthEquity closed at $63.18.</li>
<li>For Biomarin Pharmaceutical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>), Stifel upgraded the previous rating of Hold to Buy. In the second quarter, Biomarin Pharmaceutical showed an EPS of $0.07, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $92.56 and a 52-week-low of $71.35. Biomarin Pharmaceutical closed at $76.70 at the end of the last trading period.</li>
<li>Stifel upgraded the previous rating for AppLovin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) from Hold to Buy. AppLovin earned $0.04 in the second quarter, compared to $0.10 in the year-ago quarter. At the moment, the stock has a 52-week-high of $90.03 and a 52-week-low of $49.41. AppLovin closed at $68.00 at the end of the last trading period.</li>
<li>According to Jefferies, the prior rating for Banco Santander SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAN#NYSE">SAN</a>) was changed from Underperform to Hold. Banco Santander earned $0.13 in the second quarter. At the moment, the stock has a 52-week-high of $4.38 and a 52-week-low of $1.78. Banco Santander closed at $3.61 at the end of the last trading period.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
&nbsp;
<h2>Downgrades</h2>
<ul>
<li>JP Morgan downgraded the previous rating for Humanigen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGEN#NASDAQ">HGEN</a>) from Neutral to Underweight. In the second quarter, Humanigen showed an EPS of $1.20, compared to $0.79 from the year-ago quarter. At the moment, the stock has a 52-week-high of $29.20 and a 52-week-low of $7.50. Humanigen closed at $15.11 at the end of the last trading period.</li>
<li>According to Macquarie, the prior rating for Score Media and Gaming Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCR#NASDAQ">SCR</a>) was changed from Outperform to Neutral. In the third quarter, Score Media and Gaming earned $0.63. The stock has a 52-week-high of $36.32 and a 52-week-low of $12.95. At the end of the last trading period, Score Media and Gaming closed at $35.46.</li>
<li>According to Citigroup, the prior rating for Sherwin-Williams Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) was changed from Buy to Neutral. Sherwin-Williams earned $2.65 in the second quarter, compared to $7.10 in the year-ago quarter. At the moment, the stock has a 52-week-high of $768.00 and a 52-week-low of $244.67. Sherwin-Williams closed at $296.69 at the end of the last trading period.</li>
<li>According to Citigroup, the prior rating for Axalta Coating Systems Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXTA#NYSE">AXTA</a>) was changed from Buy to Neutral. Axalta Coating Sys earned $0.48 in the second quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $34.20 and a 52-week-low of $21.43. Axalta Coating Sys closed at $29.07 at the end of the last trading period.</li>
<li>According to Citigroup, the prior rating for PPG Industries Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) was changed from Buy to Neutral. In the second quarter, PPG Industries showed an EPS of $1.94, compared to $0.99 from the year-ago quarter. The current stock performance of PPG Industries shows a 52-week-high of $182.97 and a 52-week-low of $116.95. Moreover, at the end of the last trading period, the closing price was at $151.02.</li>
<li>Mizuho downgraded the previous rating for Eversource Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ES#NYSE">ES</a>) from Neutral to Underperform. In the second quarter, Eversource Energy showed an EPS of $0.79, compared to $0.76 from the year-ago quarter. The stock has a 52-week-high of $96.66 and a 52-week-low of $76.64. At the end of the last trading period, Eversource Energy closed at $91.89.</li>
<li>For Vertex Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>), Stifel downgraded the previous rating of Buy to Hold. Vertex Pharmaceuticals earned $3.11 in the second quarter, compared to $2.61 in the year-ago quarter. The current stock performance of Vertex Pharmaceuticals shows a 52-week-high of $280.99 and a 52-week-low of $185.32. Moreover, at the end of the last trading period, the closing price was at $191.37.</li>
<li>Morgan Stanley downgraded the previous rating for Cisco Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) from Overweight to Equal-Weight. For the fourth quarter, Cisco Systems had an EPS of $0.84, compared to year-ago quarter EPS of $0.80. The current stock performance of Cisco Systems shows a 52-week-high of $60.27 and a 52-week-low of $35.28. Moreover, at the end of the last trading period, the closing price was at $58.68.</li>
<li>For Kadmon Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDMN#NASDAQ">KDMN</a>), Jefferies downgraded the previous rating of Buy to Hold. Kadmon Holdings earned $0.18 in the second quarter, compared to $0.17 in the year-ago quarter. At the moment, the stock has a 52-week-high of $9.20 and a 52-week-low of $3.15. Kadmon Holdings closed at $9.07 at the end of the last trading period.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
&nbsp;
<h2>Initiations</h2>
<ul>
<li>JP Morgan initiated coverage on Westport Fuel Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) with a Neutral rating. The price target for Westport Fuel Systems is set to $5.00. For the second quarter, Westport Fuel Systems had an EPS of $0.11, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $12.95 and a 52-week-low of $1.55. At the end of the last trading period, Westport Fuel Systems closed at $3.67.</li>
<li>Citigroup initiated coverage on Lucid Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) with a Buy rating. The price target for Lucid Gr is set to $28.00. &nbsp;Moreover, at the end of the last trading period, the closing price was at $18.93.</li>
<li>UBS initiated coverage on Zogenix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZGNX#NASDAQ">ZGNX</a>) with a Buy rating. The price target for Zogenix is set to $23.00. In the second quarter, Zogenix showed an EPS of $1.05, compared to $0.96 from the year-ago quarter. At the moment, the stock has a 52-week-high of $25.31 and a 52-week-low of $13.01. Zogenix closed at $14.60 at the end of the last trading period.</li>
<li>Stephens &amp; Co. initiated coverage on Apollo Endosurgery Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEN#NASDAQ">APEN</a>) with an Overweight rating. The price target for Apollo Endosurgery is set to $15.00. In the second quarter, Apollo Endosurgery showed an EPS of $0.22, compared to $0.30 from the year-ago quarter. The stock has a 52-week-high of $10.00 and a 52-week-low of $1.25. At the end of the last trading period, Apollo Endosurgery closed at $9.64.</li>
<li>With a Neutral rating, Arete Research initiated coverage on Discovery Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DISCA#NASDAQ">DISCA</a>). The price target seems to have been set at $30.00 for Discovery. Discovery earned $0.92 in the second quarter, compared to $0.77 in the year-ago quarter. At the moment, the stock has a 52-week-high of $78.14 and a 52-week-low of $19.07. Discovery closed at $26.98 at the end of the last trading period.</li>
<li>With a Buy rating, Arete Research initiated coverage on The Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>). The price target seems to have been set at $263.00 for Walt Disney. Walt Disney earned $0.80 in the third quarter, compared to $0.08 in the year-ago quarter. The stock has a 52-week-high of $203.02 and a 52-week-low of $117.23. At the end of the last trading period, Walt Disney closed at $185.15.</li>
<li>With a Buy rating, Arete Research initiated coverage on Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>). The price target seems to have been set at $735.00 for Netflix. For the second quarter, Netflix had an EPS of $2.97, compared to year-ago quarter EPS of $1.59. The current stock performance of Netflix shows a 52-week-high of $615.60 and a 52-week-low of $458.60. Moreover, at the end of the last trading period, the closing price was at $606.05.</li>
<li>HSBC initiated coverage on Kimberly-Clark Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Hold rating. The price target for Kimberly-Clark is set to $131.00. For the second quarter, Kimberly-Clark had an EPS of $1.47, compared to year-ago quarter EPS of $2.20. The stock has a 52-week-high of $155.45 and a 52-week-low of $128.02. At the end of the last trading period, Kimberly-Clark closed at $141.49.</li>
<li>Needham initiated coverage on Upwork Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) with a Buy rating. The price target for Upwork is set to $57.00. Upwork earned $0.03 in the second quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $64.49 and a 52-week-low of $13.46. At the end of the last trading period, Upwork closed at $43.98.</li>
<li>With a Buy rating, B of A Securities initiated coverage on Arvinas Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>). The price target seems to have been set at $110.00 for Arvinas. In the second quarter, Arvinas showed an EPS of $1.03, compared to $0.65 from the year-ago quarter. At the moment, the stock has a 52-week-high of $108.47 and a 52-week-low of $19.68. Arvinas closed at $91.88 at the end of the last trading period.</li>
<li>SVB Leerink initiated coverage on Myovant Sciences Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYOV#NYSE">MYOV</a>) with a Market Perform rating. The price target for Myovant Sciences is set to $24.00. Myovant Sciences earned $0.67 in the first quarter, compared to $0.37 in the year-ago quarter. The current stock performance of Myovant Sciences shows a 52-week-high of $30.90 and a 52-week-low of $13.42. Moreover, at the end of the last trading period, the closing price was at $25.81.</li>
<li>With a Market Perform rating, SVB Leerink initiated coverage on scPharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCPH#NASDAQ">SCPH</a>). The price target seems to have been set at $6.00 for scPharmaceuticals. In the second quarter, scPharmaceuticals showed an EPS of $0.26, compared to $0.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $9.64 and a 52-week-low of $4.75. scPharmaceuticals closed at $5.95 at the end of the last trading period.</li>
<li>Credit Suisse initiated coverage on SoFi Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) with a Neutral rating. The price target for SoFi Technologies is set to $16.50. SoFi Technologies earned $0.48 in the second quarter, compared to $0.03 in the year-ago quarter. The current stock performance of SoFi Technologies shows a 52-week-high of $24.95 and a 52-week-low of $13.56. Moreover, at the end of the last trading period, the closing price was at $15.47.</li>
<li>MKM Partners initiated coverage on Denbury Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEN#NYSE">DEN</a>) with a Buy rating. The price target for Denbury is set to $96.00. Denbury earned $0.61 in the second quarter, compared to $0.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $81.37 and a 52-week-low of $15.43. Denbury closed at $70.06 at the end of the last trading period.</li>
<li>With an Overweight rating, JP Morgan initiated coverage on Blade Air Mobility Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>). The price target seems to have been set at $16.00 for Blade Air Mobility. Blade Air Mobility earned $0.15 in the third quarter. At the moment, the stock has a 52-week-high of $11.87 and a 52-week-low of $6.41. Blade Air Mobility closed at $8.79 at the end of the last trading period.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Comments

Beiersdorf

Beiersdorf (BDRFY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga